Palisade Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7M | Buy |
575,116
+85,148
| +17% | +$1.74M | 0.33% | 97 |
|
|
2025
Q1 | $9.81M | Sell |
489,968
-13,474
| -3% | -$270K | 0.28% | 111 |
|
|
2024
Q4 | $13.4M | Buy |
503,442
+1,125
| +0.2% | +$30K | 0.36% | 96 |
|
|
2024
Q3 | $14.3M | Sell |
502,317
-35,657
| -7% | -$1.02M | 0.38% | 90 |
|
|
2024
Q2 | $11.7M | Sell |
537,974
-9,193
| -2% | -$200K | 0.32% | 101 |
|
|
2024
Q1 | $12.1M | Buy |
547,167
+8,032
| +1% | +$178K | 0.32% | 102 |
|
|
2023
Q4 | $11.6M | Sell |
539,135
-63,126
| -10% | -$1.36M | 0.31% | 103 |
|
|
2023
Q3 | $10.2M | Buy |
602,261
+57
| +0% | +$963 | 0.28% | 107 |
|
|
2023
Q2 | $8.26M | Buy |
602,204
+25,186
| +4% | +$346K | 0.22% | 129 |
|
|
2023
Q1 | $13.1M | Buy |
577,018
+25,923
| +5% | +$589K | 0.35% | 96 |
|
|
2022
Q4 | $13M | Sell |
551,095
-28,849
| -5% | -$679K | 0.35% | 96 |
|
|
2022
Q3 | $15.1M | Buy |
579,944
+1,011
| +0.2% | +$26.4K | 0.43% | 78 |
|
|
2022
Q2 | $12.7M | Buy |
578,933
+169,701
| +41% | +$3.73M | 0.34% | 91 |
|
|
2022
Q1 | $18.4M | Buy |
409,232
+56,791
| +16% | +$2.55M | 0.42% | 80 |
|
|
2021
Q4 | $15.1M | Buy |
+352,441
| New | +$15.1M | 0.31% | 104 |
|